Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment
Launched by ST. OLAVS HOSPITAL · Jan 21, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and addressing the late side effects that women may experience after treatment for cervical cancer. These side effects often affect the pelvic area, leading to issues such as urinary and bowel incontinence, pelvic pain, and problems with sexual function. The goal of the study is to see if a digital pelvic floor rehabilitation program, guided by a trained physiotherapist, can help improve these issues for women who have been treated for cervical cancer within the last five years.
To be eligible for this trial, women must have been diagnosed and treated for cervical cancer (through surgery, radiation, or chemotherapy) within the past five years, and they should be able to understand Norwegian. Participants will take part in the digital rehabilitation program and will be assessed at the beginning and end of the trial to track their progress. This program is designed to be accessible for women living in rural areas, ensuring they receive the specialized care they need. The study aims to find effective ways to support these survivors in regaining their quality of life after cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women diagnosed and treated for cervical cancer (surgery, radiation- or chemo therapy) within the last five years
- • Cancer stadium I-III
- • Adequate knowledge in Norwegian.
- Exclusion Criteria:
- • - Previous pelvic radiation therapy or pelvic surgery.
About St. Olavs Hospital
St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, Trøndelag, Norway
Fredrikstad, østfold, Norway
Trondheim, , Norway
Fredrikstad, , Norway
Patients applied
Trial Officials
Signe Nilssen Stafne
Study Chair
St.Olavs university hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported